• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院的轻度 SARS-CoV-2 感染患者的口咽微生物组改变特征。

Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection.

机构信息

Anhui Provincial Centers for Disease Control and Prevention, Hefei, China.

Department of Microbiology, The Key Laboratory of Microbiology and Parasitology of Anhui Province, The Key Laboratory of Zoonoses of High Institutions in Anhui, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.

出版信息

Front Cell Infect Microbiol. 2022 Mar 15;12:824578. doi: 10.3389/fcimb.2022.824578. eCollection 2022.

DOI:10.3389/fcimb.2022.824578
PMID:35372134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8965315/
Abstract

Coronavirus disease 2019 (COVID-19) remains a serious emerging global health problem, and little is known about the role of oropharynx commensal microbes in infection susceptibility and severity. Here, we present the oropharyngeal microbiota characteristics identified by full-length 16S rRNA gene sequencing through the NANOPORE platform of oropharynx swab specimens from 10 mild COVID-19 patients and 10 healthy controls. Our results revealed a distinct oropharyngeal microbiota composition in mild COVID-19 patients, characterized by enrichment of opportunistic pathogens such as and and depletion of , , and . Based on the relative abundance of the oropharyngeal microbiota at the species level, we built a microbial classifier to distinguish COVID-19 patients from healthy controls, in which , , and were identified as the most prominent signatures for their depletion in the COVID-19 group. Several members of the genus , especially and , which were highly enriched in COVID-19 patients with higher severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load and showed a significant correlation with disease status and several routine clinical blood indicators, indicate that several bacteria may transform into opportunistic pathogen in COVID-19 patients when facing the challenges of viral infection. We also found the diver taxa and in the network of disease patients, suggesting that these oropharynx microbiota alterations may impact COVID-19 severity by influencing the microbial association patterns. In conclusion, the low sample size of SARS-CoV-2 infection patients (n = 10) here makes these results tentative; however, we have provided the overall characterization that oropharyngeal microbiota alterations and microbial correlation patterns were associated with COVID-19 severity in Anhui Province.

摘要

新型冠状病毒病(COVID-19)仍然是一个严重的全球新兴健康问题,人们对口咽共生微生物在感染易感性和严重程度中的作用知之甚少。在这里,我们通过 NANOPORE 平台对 10 例轻度 COVID-19 患者和 10 例健康对照者的口咽拭子标本进行全长 16S rRNA 基因测序,鉴定出口咽共生微生物的特征。我们的结果显示,轻度 COVID-19 患者的口咽共生微生物组成明显不同,表现为机会性病原体如 和 的丰度增加, 和 、 和 的丰度减少。基于种水平口咽共生微生物的相对丰度,我们构建了一个微生物分类器,以区分 COVID-19 患者和健康对照者,其中 、 、 和 被鉴定为 COVID-19 组中缺失的最显著特征。几个属的成员,特别是 和 ,在 COVID-19 患者中高度富集,这些患者的严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)病毒载量较高,与疾病状态和几个常规临床血液指标显著相关,表明在 COVID-19 患者中,当面临病毒感染的挑战时,几种细菌可能转化为机会性病原体。我们还发现了疾病患者网络中的分类群 和 ,表明这些口咽共生微生物的改变可能通过影响微生物关联模式来影响 COVID-19 的严重程度。总之,这里 SARS-CoV-2 感染患者的样本量(n = 10)较小,因此这些结果只是初步的;然而,我们已经提供了总体特征,即口咽共生微生物的改变和微生物相关性模式与安徽省 COVID-19 的严重程度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f331/8965315/c27f14e009e5/fcimb-12-824578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f331/8965315/5d688bead9be/fcimb-12-824578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f331/8965315/e8be16b5b70e/fcimb-12-824578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f331/8965315/c45a0f7670f1/fcimb-12-824578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f331/8965315/c27f14e009e5/fcimb-12-824578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f331/8965315/5d688bead9be/fcimb-12-824578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f331/8965315/e8be16b5b70e/fcimb-12-824578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f331/8965315/c45a0f7670f1/fcimb-12-824578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f331/8965315/c27f14e009e5/fcimb-12-824578-g004.jpg

相似文献

1
Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection.住院的轻度 SARS-CoV-2 感染患者的口咽微生物组改变特征。
Front Cell Infect Microbiol. 2022 Mar 15;12:824578. doi: 10.3389/fcimb.2022.824578. eCollection 2022.
2
Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.宏基因组分析揭示 COVID-19 患者口咽微生物群的改变。
Signal Transduct Target Ther. 2021 May 13;6(1):191. doi: 10.1038/s41392-021-00614-3.
3
Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.SARS-CoV-2 对住院患者的人鼻咽喉微生物群影响有限。
Microbiol Spectr. 2022 Dec 21;10(6):e0219622. doi: 10.1128/spectrum.02196-22. Epub 2022 Nov 9.
4
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.COVID-19 严重程度和呼吸道微生物组免疫反应特征。
mBio. 2021 Aug 31;12(4):e0177721. doi: 10.1128/mBio.01777-21. Epub 2021 Aug 17.
5
Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.唾液微生物组的多样性、组成和网络可区分 COVID-19 发作的严重程度,这是通过对 16S rRNA 可变区 V1-V3 序列的分析揭示的。
mSystems. 2023 Aug 31;8(4):e0106222. doi: 10.1128/msystems.01062-22. Epub 2023 Jun 13.
6
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing.基于 16S rDNA 测序的 COVID-19 患者鼻/咽微生物群落研究。
Int J Environ Res Public Health. 2021 Feb 23;18(4):2174. doi: 10.3390/ijerph18042174.
7
Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.SARS-CoV-2 患者口咽微生物组的时间动态变化表明,即使病毒清除后,仍持续存在微生态失调。
NPJ Biofilms Microbiomes. 2022 Aug 24;8(1):67. doi: 10.1038/s41522-022-00330-y.
8
SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.SARS-CoV-2 感染和病毒载量与上呼吸道微生物组有关。
J Allergy Clin Immunol. 2021 Apr;147(4):1226-1233.e2. doi: 10.1016/j.jaci.2021.02.001. Epub 2021 Feb 9.
9
Comparative analysis of oropharyngeal microbiota in healthcare workers post-COVID-19.医护人员 COVID-19 后患咽部微生物组的对比分析。
Front Cell Infect Microbiol. 2024 May 17;14:1347345. doi: 10.3389/fcimb.2024.1347345. eCollection 2024.
10
High abundance of butyrate-producing bacteria in the naso-oropharynx of SARS-CoV-2-infected persons in an African population: implications for low disease severity.在非洲人群中,SARS-CoV-2 感染患者的鼻咽部存在大量产生丁酸的细菌:这可能与疾病严重程度较低有关。
BMC Infect Dis. 2024 Sep 20;24(1):1020. doi: 10.1186/s12879-024-09948-z.

引用本文的文献

1
SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolution.恒河猴中的SIV/SARS-CoV-2合并感染会影响病毒脱落、宿主免疫、微生物群和病毒进化。
Front Immunol. 2025 May 20;16:1587688. doi: 10.3389/fimmu.2025.1587688. eCollection 2025.
2
SIV/SARS-CoV-2 co-infection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolution.恒河猴中的SIV/SARS-CoV-2共感染会影响病毒脱落、宿主免疫、微生物群和病毒进化。
Res Sq. 2025 Mar 26:rs.3.rs-6033850. doi: 10.21203/rs.3.rs-6033850/v1.
3
Microbiome-Mucosal Immunity Nexus: Driving Forces in Respiratory Disease Progression.

本文引用的文献

1
Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients.人类口咽微生物组在 SARS-CoV-2 感染及康复患者中的特征。
Adv Sci (Weinh). 2021 Oct;8(20):e2102785. doi: 10.1002/advs.202102785. Epub 2021 Aug 22.
2
The role of oral bacteria in inflammatory bowel disease.口腔细菌在炎症性肠病中的作用。
Nat Rev Gastroenterol Hepatol. 2021 Oct;18(10):731-742. doi: 10.1038/s41575-021-00488-4. Epub 2021 Aug 16.
3
Profiling of Oral Microbiota and Cytokines in COVID-19 Patients.新冠病毒感染患者口腔微生物群和细胞因子分析
微生物群-黏膜免疫关系:呼吸系统疾病进展的驱动因素
J Microbiol. 2024 Sep;62(9):709-725. doi: 10.1007/s12275-024-00167-4. Epub 2024 Sep 6.
4
Discovery of Bacterial Key Genes from 16S rRNA-Seq Profiles That Are Associated with the Complications of SARS-CoV-2 Infections and Provide Therapeutic Indications.从16S rRNA测序图谱中发现与SARS-CoV-2感染并发症相关并提供治疗指征的细菌关键基因。
Pharmaceuticals (Basel). 2024 Mar 28;17(4):432. doi: 10.3390/ph17040432.
5
Associated Bacterial Coinfections in COVID-19-Positive Patients.COVID-19 阳性患者的相关细菌合并感染。
Medicina (Kaunas). 2023 Oct 19;59(10):1858. doi: 10.3390/medicina59101858.
6
A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.一项关于印度三波新冠疫情期间感染新冠病毒个体鼻咽微生物群的横断面研究。
Front Microbiol. 2023 Sep 6;14:1238829. doi: 10.3389/fmicb.2023.1238829. eCollection 2023.
7
Nanopore sequencing technology and its applications.纳米孔测序技术及其应用。
MedComm (2020). 2023 Jul 10;4(4):e316. doi: 10.1002/mco2.316. eCollection 2023 Aug.
8
Potential interaction between the oral microbiota and COVID-19: a meta-analysis and bioinformatics prediction.口腔微生物群与 COVID-19 之间的潜在相互作用:一项荟萃分析和生物信息学预测。
Front Cell Infect Microbiol. 2023 Jun 7;13:1193340. doi: 10.3389/fcimb.2023.1193340. eCollection 2023.
9
Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.SARS-CoV-2 对住院患者的人鼻咽喉微生物群影响有限。
Microbiol Spectr. 2022 Dec 21;10(6):e0219622. doi: 10.1128/spectrum.02196-22. Epub 2022 Nov 9.
Front Microbiol. 2021 Jul 30;12:671813. doi: 10.3389/fmicb.2021.671813. eCollection 2021.
4
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.住院 COVID-19 患者中肠道和口腔微生物群的改变及其与 SARS-CoV-2 病毒载量的关系。
NPJ Biofilms Microbiomes. 2021 Jul 22;7(1):61. doi: 10.1038/s41522-021-00232-5.
5
Case Report: as a Rare Pathogen of Mitral Endocarditis.病例报告:作为二尖瓣心内膜炎的一种罕见病原体。
Front Cardiovasc Med. 2021 Apr 29;8:648213. doi: 10.3389/fcvm.2021.648213. eCollection 2021.
6
Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.宏基因组分析揭示 COVID-19 患者口咽微生物群的改变。
Signal Transduct Target Ther. 2021 May 13;6(1):191. doi: 10.1038/s41392-021-00614-3.
7
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19.新冠病毒感染患者口腔和肠道微生物组及脂质组的变化。
Gut. 2021 Jul;70(7):1253-1265. doi: 10.1136/gutjnl-2020-323826. Epub 2021 Mar 31.
8
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.肠道微生物群落组成反映了 COVID-19 患者的疾病严重程度和功能失调的免疫反应。
Gut. 2021 Apr;70(4):698-706. doi: 10.1136/gutjnl-2020-323020. Epub 2021 Jan 11.
9
Potential implications of SARS-CoV-2 oral infection in the host microbiota.严重急性呼吸综合征冠状病毒2型口腔感染对宿主微生物群的潜在影响。
J Oral Microbiol. 2020 Nov 29;13(1):1853451. doi: 10.1080/20002297.2020.1853451.
10
The Gastrointestinal Tract Is an Alternative Route for SARS-CoV-2 Infection in a Nonhuman Primate Model.胃肠道是 SARS-CoV-2 在非人类灵长类动物模型中感染的另一种途径。
Gastroenterology. 2021 Apr;160(5):1647-1661. doi: 10.1053/j.gastro.2020.12.001. Epub 2020 Dec 9.